Long-term hepatitis control efforts dramatically reduce HBV and HCV burden in Japan
Peer-Reviewed Publication
Updates every hour. Last Updated: 25-Jun-2026 09:16 ET (25-Jun-2026 13:16 GMT/UTC)
Hiroshima University researchers use the previous 20 years of data to project what the currently implemented treatment and management strategy does for the HBV and HCV cases in 2050.
Cancers caused by mutations in the KRAS gene are challenging to treat, and current KRAS inhibitor therapies can leave behind reversible drug-tolerant persister (DTP) cells that survive therapy, contributing to tumor regrowth and relapse. Researchers from Chiba University found that these surviving cells adapt by reshaping their metabolism. By targeting these metabolic adaptations, the team succeeded in reducing the survival of DTP cells. The findings may help develop therapies to reduce relapse in KRAS-mutant cancers.
The addition of StudyFinder AI and Osmosis AI combines trusted content from books, videos and 3D models with user-centric AI to improve efficiency and productivity in medical education
Obesity affected nearly a third of adults in England in 2025, new research suggests. The study by researchers from the University of Cambridge, the British Heart Foundation Data Science Centre at Health Data Research UK and The George Institute for Global Health also revealed the most disadvantaged groups are bearing a disproportionate burden of the obesity crisis, and this gap has widened in the wake of the COVID-19 pandemic.
A study of more than 60 countries shows those with faster declines in the social acceptability of intimate partner violence against women also tend to have had faster reductions in rates of such violence, as well as faster human development improvements. Irina Vartanova of the Institute for Futures Studies in Stockholm, Sweden, and colleagues present these findings in the open-access journal PLOS Global Health.